Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor and Aspirin for Prevention of Cardiovascular Events After CABG
NCT01373411Phase 4Completed
- Sponsor
- UBC Division of Cardiology
- Start
- Sep 2011
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ticagrelor in coronary artery disease (CAD), sponsored by UBC Division of Cardiology. Started Sep 2011; status: completed.
02
Drugs
ticagrelor
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT01373411.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01373411.